Hepion Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2…

Biotechnology
US, Edison [HQ]

Income Statements

Loading...
End of HEPA's Analysis
CIK: 1583771 CUSIP: 426897104 ISIN: US4268973025 LEI: - UEI: -
Secondary Listings
HEPA has no secondary listings inside our databases.